The organ-on-a-chip (OOC) is a specific type of three-dimensional (3D) multi-channel microfluidic cell culture chip that simulates the activities, mechanics and physiological reaction of entire organs & organ systems. It is a type of artificial organ. It constitutes the subject material of important biomedical-engineering research, more accurately in bio-MEMS. Organ-on-chip devices are primarily used in in-vitro evaluation of real-time imaging, biochemical, and metabolic and genetic activities of living cells present in the functional-tissue. Increasingly expanding the application scope of OOCs is likely to boost the organ-on-chip market demand in the coming years.
Referring to the study, North America Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity. Some of the key companies that are currently operating in the North-America organ-on-chip market include InSphero AG, CN Bio Innovations, Ltd., Organovo, Inc., Hurel Corporation, AxoSim Inc., Nortis Inc., Tara Biosystems Inc., Organovo, Inc., BiomimX SRL, SynVivo, Inc., TissUse GmbH, Organovo, Inc., MIMETAS BV, Emulate Inc., Cherry Biotech and among others. The major players in the organ-on-chip market make a significant contribution by offering different types of products and increasing their geographical presence around the world.
The North-America organ-on-chip market is experiencing massive growth, largely due to the increasing demand for animal testing alternatives to drug testing, as they offer a potentially more ethical way to model disease. In addition, it provides a higher level of knowledge regarding drug toxicity & efficacy. In addition, organ-on-a-chip technology can reduce drug development costs, leading to the adoption of organ-on-a-chip technology.
Some of the key applications of OOCs are drug discovery, toxicology research, and more. Drug discovery is likely to be the dominant segment and would therefore; capture the maximum portion of the global market. The North-American organ-on-chip industry is expected to be driven by the application-driven drug discovery segment. Therefore, this segment is predicted to hold a noteworthy market share. In addition, the toxicity & efficacy of drug in different organs is assessed using this innovative method and increasing number of such processes in various regions of the world is estimated to favor the studied market. With the increasing number of leading universities and non-profit research centers adopting various organ-on-chip applications, research organizations are also growing in the organ-on-chip market.
Geographically, the North-America is forecast to lead the organ-on-chip market and is projected to maintain its dominance with a noteworthy CAGR throughout the forecast period. The factors driving the growth of organ-on-chip industry in the region include increase in toxicological testing of chemicals on the different types of organ cells, rise in investment by public & private sectors, and rapid adoption of technological advancement. Furthermore, the occurrence of pharmaceutical companies & key market players, the availability of advanced organ-on-chip models, the government supports in funding form, and rise in awareness-raising initiatives to encourage the bio-chip adoption are also driving the growth of organ-on-chip market.
For More Information, click on the link below:-
North America Organ-on-Chip Market Research Report
Related Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
